CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stuen, S.
Right arrow Articles by Moum, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stuen, S.
Right arrow Articles by Moum, T.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, December 2005, p. 1448-1450, Vol. 12, No. 12
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.12.1448-1450.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Unidirectional Suppression of Anaplasma phagocytophilum Genotypes in Infected Lambs

Snorre Stuen,1* Hilde Dahl,1 Karin Bergström,2 and Truls Moum1

Norwegian School of Veterinary Science, Department of Production Animal Clinical Sciences, Sandnes, Norway,1 National Veterinary Institute, Department of Bacteriology, Uppsala, Sweden2

Received 20 July 2005/ Returned for modification 6 September 2005/ Accepted 10 October 2005


    ABSTRACT
 Top
 Abstract
 Text
 References
 
Five-month-old lambs were simultaneously infected with different doses of two 16S rRNA genetic variants of Anaplasma phagocytophilum and thereafter followed for clinical observation and blood sampling. The result of the study indicates a unidirectional suppression of genotypes in infected lambs, at least during a certain period of an A. phagocytophilum infection.


    TEXT
 Top
 Abstract
 Text
 References
 
The rickettsia Anaplasma phagocytophilum (formerly Ehrlichia phagocytophila) causes tick-borne fever in domestic ruminants, a disease which has also been diagnosed in several other animal species and human beings (2, 10, 23). In Europe, A. phagocytophilum is mainly transmitted by Ixodes ricinus ticks.

Based on sequencing of the 5' part of the A. phagocytophilum 16S rRNA gene, four genetic variants have been identified in sheep (16). Although the variants can be distinguished in the laboratory on the basis of only 1 or 2 nucleotide differences in the 16S rRNA gene, studies indicate that there are biological, ecological, and pathological differences between them (11, 18).

Simultaneous infections of several A. phagocytophilum 16S rRNA gene variants have been detected in individual lambs (16). A recent study indicated a possible interaction between these genetic variants (19). In the present study, susceptible lambs were simultaneously infected with various doses of two 16S rRNA variants in order to monitor further the occurrence of variants during an A. phagocytophilum infection.

Five-month-old lambs of the Norwegian White Sheep breed were used in this trial. None of the lambs had previously been on I. ricinus-infested pasture, and the lambs were kept indoors during the whole experimental period. Two 16S rRNA variants of A. phagocytophilum, i.e., variants 1 and 2 (GenBank accession numbers M73220 and AF336220, respectively), were used as the inoculum (18). Briefly, six lambs were inoculated with various doses of fresh heparinized blood containing the two 16S rRNA variants of A. phagocytophilum. Each of two lambs was given an infection dose of variant 1 (approximately 2.0 x 106 infected neutrophils [14]) and 1:1,000 (diluted in physiological saline) of that infection dose of variant 2 (group 1), and for another two lambs these doses were reversed (group 2). In addition, each of two lambs was infected with approximately 2.0 x 106 infected neutrophils of both variants (group 3). Two lambs were uninfected controls. All lambs were followed for the next six weeks for clinical observation and blood sampling.

Rectal temperatures were measured daily in all lambs throughout the experimental period, and the clinical manifestations were calculated (22). Blood samples were collected into EDTA daily during the fever period following the inoculation and twice a week after the fever had subsided. From these blood samples, hematological values, including total and differential leukocyte counts, were determined electronically (Technicon H1; Miles Inc.) and blood smears were prepared and stained with May-Grünwald Giemsa.

DNA amplifications were carried out on a PTC-200 instrument (MJ Research). An initial PCR was performed using primers 16S-F5 (5'-AGTTTGATCATGGTTCAGA-3') and ANA-R4B (5'-CGAACAACGCTTGC-3') for amplification of a 507-bp fragment of the 16S rRNA gene in A. phagocytophilum. The subsequent seminested reaction with primers 16S-F5 and ANA-R5 (5'-TCCTCTCAGACCAGCTATA-3') produced a 282-bp fragment. PCR products were sequenced directly using Big Dye terminator cycle sequencing chemistry and capillary electrophoresis (ABI 310; Applied Biosystems), and A. phagocytophilum variants were detected by visual inspection of the chromatograms (20).

In addition, sera were collected weekly and analyzed using an indirect immunofluorescence antibody assay with Ehrlichia equi as an antigen (1, 9, 15).

After inoculation, all lambs reacted with typical signs of A. phagocytophilum infection, i.e., high fever (>41.0°C), neutropenia (<0.7 x 109 cells/liter), and cytoplasmatic inclusions in neutrophils. The infected lambs developed positive antibody titers to E. equi between 7 and 14 days postinoculation. None of these reactions were seen in controls.

No clear differences in clinical manifestations and serologic responses were observed between the lamb groups. The highest number of infected neutrophils in lambs in group 2 (infected with a full dose of variant 2 and 1:1,000 of the infection dose of variant 1) was observed on day 6, while the highest number of infected neutrophils was observed on day 3 in the other two groups.

Only variant 1 was found by gene sequencing in acutely infected lambs in groups 1 to 3. In group 2, variant 2 was detected on days 2, 3, and 4, while variant 1 was detected from day 4. From day 6 to day 42, variant 1 was detected 53 times, while variant 2 was detected 6 times. Simultaneous infection with both variants was not detected in this period (Table 1).


View this table:
[in this window]
[in a new window]
 
TABLE 1. The occurrence of A. phagocytophilum 16S rRNA gene variants 1 and 2 in the peripheral blood of three groups of experimentally inoculated lambsa

 
The two 16S rRNA variants have earlier been used separately in infection studies in lambs. Lambs infected with variant 1 showed more severe clinical manifestations than lambs infected with variant 2. In addition, lambs infected with variant 1 reacted with a positive antibody titer after 14 days, while variant 2-infected lambs were seronegative 4 weeks postinoculation. However, rickettsemias of at least 10 days’ duration were observed for both variants during the acute phase of the infection (18).

In the present trial, the double-infected lambs reacted clinically, hematologically, and serologically as though they were infected with variant 1. No clear differences between lamb groups were observed in either clinical manifestations or serologic responses, although the infection rate during the first days of the infection seemed to be lower for group 2 lambs than for the other lamb groups. A delayed onset of clinical symptoms in group 2 may have been caused by a low inoculation dose of variant 1. It has been shown earlier that A. phagocytophilum infection in lambs is not dose dependent, except for the incubation period (14).

Infection (superinfection) exclusion is a phenomenon that was first described in bacteriophages (13) but was later confirmed in animal viruses and rickettsiae, such as Anaplasma marginale (5, 7). The results of the present study do not support the existence of infection exclusion in A. phagocytophilum-infected lambs but indicate that suppression of genotypes occurs during the acute phase of the infection. This interaction is unidirectional and not dose dependent, as has also been observed when two ank gene variants of A. phagocytophilum were inoculated simultaneously in BALB/c mice (R. F. Massung, V. E. Pitzer, and M. L. Levin, Abstr. 18th Meet. Am. Soc. Rickettsiol., abstr. 113, 2003). In contrast, when cattle were infected simultaneously with variants of the closely related A. marginale, only the variant that was inoculated at the highest dose became established (7). The assumption of infection suppression is also supported by the fact that double infection has been observed only during the acute phase of the infection and not in the persistent phase.

Although both variants were detected in the persistent phase of the infection, one variant seems to dominate. The dominant variant is involved in most fatal cases of tick-borne fever and seems to be the most widespread A. phagocytophilum variant in sheep in Norway (17, 18). The reason for this dominance is unknown, but factors such as growth rate, immunogenicity, receptor competition, and antigenic variation may be involved in the infectivity and interaction of A. phagocytophilum variants (3, 4, 12).

The prevalence of A. phagocytophilum infection in I. ricinus ticks in Europe has been found to vary from 1.5 to 34% (6, 21). Natural hosts may therefore be infested with several A. phagocytophilum-infected ticks. Simultaneous infection with two variants of the bacterium has been observed earlier in 3 of 40 (7.5%) acutely infected lambs (16). Recently, an acutely infected cow was also found to be infected with two A. phagocytophilum variants (20). One should therefore be aware of the possibility that blood in the acute phase of the infection may harbor more than one variant. However, it may not always be possible to detect every variant involved in a single blood sample.

Further studies are in progress to more closely investigate the suppression of genotypes in infected sheep. Studies should also be done with several potential hosts and ticks to analyze the implication of this phenomenon for the epidemiology and control of genotypes of A. phagocytophilum, for instance to investigate if individual transmission of single variants occurs, as has recently been assumed for genotypes of A. marginale (8).


    FOOTNOTES
 
* Corresponding author. Mailing address: Norwegian School of Veterinary Science, Department of Production Animal Clinical Sciences, Kyrkjevegen 332/334, N.4325 Sandnes, Norway. Phone: 47 51603510. Fax: 47 51603509. E-mail: Snorre.Stuen{at}veths.no. Back


    REFERENCES
 Top
 Abstract
 Text
 References
 

  1. Artursson, K., A. Gunnarsson, U.-B. Wikström, and E. Olsson Engvall. 1999. A serological and clinical follow-up in horses with confirmed equine granulocytic ehrlichiosis. Equine Vet. J. 31:473-477.[Medline]
  2. Bakken, J. S., J. S. Dumler, S.-M. Chen, M. R. Eckman, L. L. Van Etta, and D. H. Walker. 1994. Human granulocytic ehrlichiosis in the upper midwest United States. A new species emerging? JAMA 272:212-218.[Abstract]
  3. Barbet, A. F., P. F. M. Meeus, M. Bélanger, M. V. Bowie, J. Yi, A. M. Lundgren, A. R. Alleman, S. J. Wong, F. K. Chu, U. G. Munderloh, and S. D. Jauron. 2003. Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect. Immun. 71:1706-1718.[Abstract/Free Full Text]
  4. Carlyn, J. A., and E. Fikrig. 2003. Invasion and survival strategies of Anaplasma phagocytophilum. Cell. Microbiol. 5:734-754.
  5. Christen, L., J. Seto, and E. G. Niles. 1990. Superinfection exclusion of vaccinia virus in virus-infected cell cultures. Virology 174:35-42.[CrossRef][Medline]
  6. Christova, I., L. Schouls, I. van de Pol, J. Park, S. Panayotov, S. Lefterova, T. Kantardjiev, and J. S. Dumler. 2001. High prevalence of granulocytic ehrlichiae and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Bulgaria. J. Clin. Microbiol. 39:4172-4174.[Abstract/Free Full Text]
  7. de la Fuente, J., J. C. Garcia-Garcia, E. F. Blouin, J. T. Saliki, and K. M. Kocan. 2002. Infection of tick cells and bovine erythrocytes with one genotype of the intracellular ehrlichia Anaplasma marginale excludes infection with other genotypes. Clin. Diagn. Lab. Immunol. 9:658-668.[Abstract/Free Full Text]
  8. de la Fuente, J., E. F. Blouin, and K. M. Kocan. 2003. Infection exclusion of the rickettsial pathogen Anaplasma marginale in the tick vector Dermacentor variabilis. Clin. Diagn. Lab. Immunol. 10:182-184.[Abstract/Free Full Text]
  9. Dumler, J. S., K. M. Asanovich, J. S. Bakken, P. Richter, R. Kimsey, and J. E. Madigan. 1995. Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic ehrlichia. J. Clin. Microbiol. 33:1098-1103.[Abstract]
  10. Foley, J. E., P. Foley, M. Jecker, P. K. Swift, and J. E. Madigan. 1999. Granulocytic ehrlichiosis and tick infestation in mountain lions in California. J. Wildl. Dis. 35:703-709.[Abstract]
  11. Massung, R. F., M. J. Mauel, J. H. Owens, N. Allan, J. W. Courtney, K. C. Stafford III, and T. N. Mather. 2002. Genetic variants of Ehrlichia phagocytophila, Rhode Island and Connecticut. Emerg. Infect. Dis. 8:467-472.[Medline]
  12. Park, J., K. Seong Choi, and J. S. Dumler. 2003. Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect. Immun. 71:4018-4025.[Abstract/Free Full Text]
  13. Soller, A., and H. T. Epstein. 1965. Biochemical and immunological aspects of the exclusion of lambda by superinfection with T4. Virology 26:715-726.[CrossRef][Medline]
  14. Stuen, S., and K. Artursson. 2000. Effects of the dose of Ehrlichia phagocytophila on the severity of experimental infections in lambs. Vet. Rec. 146:669-672.[Abstract/Free Full Text]
  15. Stuen, S., and K. Bergström. 2001. Serological investigation of granulocytic Ehrlichia infection in sheep in Norway. Acta Vet. Scand. 42:331-338.[Medline]
  16. Stuen, S., I. van de Pol, K. Bergström, and L. M. Schouls. 2002. Identification of Ehrlichia phagocytophila variants in blood from sheep in Norway. J. Clin. Microbiol. 40:3192-3197.[Abstract/Free Full Text]
  17. Stuen, S., S. Nevland, and T. Moum. 2002. Fatal cases of tick-borne fever (TBF) in sheep caused by several 16S rRNA gene variants of Anaplasma phagocytophilum. Ann. N. Y. Acad. Sci. 990:433-434.
  18. Stuen, S., K. Bergström, M. Petrovec, I. van de Pol, and L. M. Schouls. 2003. Differences in clinical manifestations and hematological and serological responses after experimental infection with genetic variants of Anaplasma phagocytophilum in sheep. Clin. Diagn. Lab. Immunol. 10:692-695.[Abstract/Free Full Text]
  19. Stuen, S., S. K. Whist, K. Bergström, and T. Moum. 2005. Possible exclusion of genotypes in Anaplasma phagocytophilum-infected lambs. Vet. Rec. 156:518-520.[Free Full Text]
  20. Stuen, S., A. Solli Oppegaard, K. Bergström, and T. Moum. 2005. Anaplasma phagocytophilum infection in north Norway. The first laboratory confirmed case. Acta Vet. Scand. 46:167-171.[Medline]
  21. Walker, A. R., M. P. Alberdi, K. A. Urquhart, and H. Rose. 2001. Risk factors in habitats of the tick Ixodes ricinus influencing human exposure to Ehrlichia phagocytophila bacteria. Med. Vet. Entomol. 15:40-49.[Medline]
  22. Woldehivet, Z., and G. R. Scott. 1982. Immunological studies on tick-borne fever in sheep. J. Comp. Pathol. 92:457-467.[CrossRef][Medline]
  23. Woldehiwet, Z., and G. R. Scott. 1993. Tick-borne (pasture) fever, p. 233-254. In Z. Woldehiwet and M. Ristic (ed.), Rickettsial and chlamydial diseases of domestic animals. Pergamon Press, Oxford, England.


Clinical and Diagnostic Laboratory Immunology, December 2005, p. 1448-1450, Vol. 12, No. 12
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.12.1448-1450.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stuen, S.
Right arrow Articles by Moum, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stuen, S.
Right arrow Articles by Moum, T.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS